Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
16 February to 12 March 1988
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1988
Report date:
1988

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
EU Method B.6 (Skin Sensitisation)
Deviations:
not specified
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
not specified
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
An adequate and relevent in vivo study is available.

Test material

Constituent 1
Reference substance name:
ODB-2
IUPAC Name:
ODB-2
Constituent 2
Chemical structure
Reference substance name:
6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one
EC Number:
403-830-5
EC Name:
6'-(dibutylamino)-3'-methyl-2'-(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)-xanthen]-3-one
Cas Number:
89331-94-2
Molecular formula:
C35 H36 N2 O3
IUPAC Name:
6'-(dibutylamino)-3'-methyl-2'-(phenylamino)-3H-spiro[2-benzofuran-1,9'-xanthen]-3-one
Details on test material:
- Name of test material (as cited in study report): ODB-2
- Substance type: Colour precursor for heat sensitive record sheets
- Physical state: White powder
- Analytical purity: > 99%
- Impurities (identity and concentrations): No data
- Purity test date: No data
- Lot/batch No.: 61-24101
- Expiration date of the lot/batch: No data
- Stability under test conditions:
- Storage condition of test material: Ambient in the dark
- Other: date received 26 January 1988

In vivo test system

Test animals

Species:
guinea pig
Strain:
Dunkin-Hartley
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Commercial laboratory animal supplier
- Age at study initiation:
- Weight at study initiation: 460 - 536 g
- Housing: suspended cages with wire mesh floors
- Diet: Vitamin C-enriched guinea-pig diet F.D.1.,ad libitum. Hay was given weekly.
- Water: ad libitum
- Acclimation period: 19 days

ENVIRONMENTAL CONDITIONS
- Temperature: 21°C
- Humidity: 30 - 70%
- Air changes (per hr): 15
- Photoperiod: 12 hrs dark / 12 hrs light

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal and epicutaneous
Vehicle:
other: Alembicol D
Concentration / amount:
Induction
Intradermal injection: 0.05% w/w in Alembicol D.
Topical application: 50% w/w in Alembicol D.

Challenge
Topical application: 50% and 25% w/w in Alembicol D.
Challengeopen allclose all
Route:
epicutaneous, occlusive
Vehicle:
other: Alembicol D
Concentration / amount:
Induction
Intradermal injection: 0.05% w/w in Alembicol D.
Topical application: 50% w/w in Alembicol D.

Challenge
Topical application: 50% and 25% w/w in Alembicol D.
No. of animals per dose:
20
Details on study design:
RANGE FINDING TESTS:
The intradermal and topical irritancy of a range of dilutions of ODB-2 was investigated to identify (a) irritant test substance concentrations suitable for the induction phase of the main study and (b) non-irritant concentrations by the topical route of administration for the challenge phase.

A concentration of 50% in AlembicolD was the maximum practical concentration that could be prepared and dosed topically. Based on the results of the preliminary investigations, the following concentrations of ODB-2 were selected:

Induction
Intradermal injection: 0.05% w/w in Alernbicol D.
Topical application: 50% w/w in Alernbicol D.

Challenge
Topical application: 50% and 25% w/w in Alernbicol D.

Alernbicol D is a product of coconut oil. By fractionating the fatty acids of coconut oil and re-esterifyinq with glycerine, a Medium Chain Triglyceride (MCT) Oil is produced. Alernbicol D is such an oil. It is advantageous in this type of test in that it is stable, has a low viscosity and surface tension and is easily absorbed into the skin. These properties made it ideal as a vehicle for intradermal injections and topical applications.

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 3
- Exposure period: 1 week
- Test groups: 1
- Control group: yes, 10 animals
- Site: right and left dorsal
- Frequency of applications:
- Duration: two weeks
- Concentrations:
1. Freund's complete adjuvant* was diluted with an equal volume of water for irrigation.
2. ODB-2, 0.05% w/w in Alembicol D.
3. ODB-2, 0.05% w/w in a 50 : 50 mixture of Freund's complete adjuvant and Alembicol D.

B. CHALLENGE EXPOSURE
- No. of exposures: 2
- Day(s) of challenge:
- Exposure period: 3 days
- Test groups: 20 animals
- Control group: 10 animals
- Site: Shaved flanks.
- Concentrations: 0.2 ml of ODB-2, 50% w/w in Alembico1 D and applied to an anterior site on the flank. ODB-2, 25% w/w in Alembicol D was applied in a similar manner to a posterior site.
- Evaluation (hr after challenge): 24, 48 and 72 hours

OTHER:
Challenge controls:
The test and control animals were challenged topically two weeks after the induction period using ODB-2, 50% and 25% w/w in Alembicol D.
Positive control substance(s):
yes
Remarks:
The sensitivity of the guinea-pig strain used is checked periodically at H.R.C. with formalin, a known sensitiser.

Results and discussion

Positive control results:
1988; 10 animals tested all positive with formalin.

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
72
Group:
negative control
Dose level:
ODB-2, 25% and 50%w/w in Alembicol D
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 72.0. Group: negative control. Dose level: ODB-2, 25% and 50%w/w in Alembicol D . No with. + reactions: 0.0. Total no. in groups: 10.0.
Key result
Reading:
1st reading
Hours after challenge:
72
Group:
test chemical
Dose level:
ODB-2, 25% and 50% in Alembicol D.
No. with + reactions:
0
Total no. in group:
20
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 72.0. Group: test group. Dose level: ODB-2, 25% and 50% in Alembicol D.. No with. + reactions: 0.0. Total no. in groups: 20.0.
Reading:
1st reading
Hours after challenge:
72
Group:
positive control
Dose level:
10% formaldehyde aqueous solution (Formalin)
No. with + reactions:
10
Total no. in group:
10
Clinical observations:
not reported
Remarks on result:
positive indication of skin sensitisation

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
In this screening test, performed in twenty albino guinea-pigs, ODB-2 did not produce evidence of delayed contact hypersensitivity.